Home » Topics » BioWorld Science

BioWorld Science
RSS

Virulent factors of P. aeruginosa isolates are upregulated under anaerobic conditions

Nov. 9, 2021

Prelude Therapeutics presents new Mcl-1 inhibitors

Nov. 9, 2021

Glucagon receptor agonists discovered at Intarcia Therapeutics

Nov. 9, 2021

New HSD17B13 inhibitors identified at Inipharm

Nov. 9, 2021

Aptamer Sciences patents insulin receptor-specific aptamers

Nov. 9, 2021

QIMR describes CAR-T cells derived from CD49f+ T cells

Nov. 9, 2021

Unveiling the evolutionary acquisition of antifungal drug resistance in Candida glabrata

Nov. 9, 2021

MDM2 and MDMX have a p53-independent role in cell-cycle progression in the absence of wild-type p53

Nov. 9, 2021

Researchers develop useful murine model of Bardet-Biedl syndrome

Nov. 9, 2021

Studies of KL-11743 detail potential oncolytic activity of glucose transporter inhibitors

Nov. 8, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...